tipifarnib has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso-Alonso, R; Burrows, F; Esteve-Codina, A; Fuste, B; García-Diaz, N; Gualberto, A; Gut, M; Martínez, N; Merino, D; Mondéjar, R; Pérez, C; Piris, MÁ; Rodríguez, M; Scholz, C; Vaqué, JP | 1 |
| Astolfi, A; Biagi, C; Chiarini, F; Franzoni, M; Masetti, R; Melchionda, F; Pession, A; Serravalle, S | 1 |
2 other study(ies) available for tipifarnib and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma.
Topics: Apoptosis; Biomarkers, Tumor; Cell Cycle; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Humans; Inhibitory Concentration 50; Lymphoma, T-Cell; Mutation; Phenotype; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Quinolones; Signal Transduction; T-Lymphocytes | 2020 |
Pediatric early T-cell precursor leukemia with NF1 deletion and high-sensitivity in vitro to tipifarnib.
Topics: Antineoplastic Agents; Child; Female; Humans; In Vitro Techniques; Neurofibromin 1; Polymorphism, Single Nucleotide; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Quinolones; Sequence Deletion | 2010 |